Sell HCWB by Dec 8, 2026.

Fellow Investors, if you are holding or tracking HCW Biologics (**$HCWB**), you need to look at the recent sequencing of SEC filings (Form S-1, 8-K, and Schedule 14A). There is an explicit, multi-layered asset-shifting and market-suppression scheme under way that closely replicates the **Altor BioScience** corporate misconduct patterns litigated in 2017 under the same executive block—CEO **Dr. Hing C. Wong**, CSO **Dr. Peter Rhode**, and Senior VP **Lee D. Flowers**. **1. Non-Dilutive CAR-T Revenue Hiding (The Akron Deception)** On September …